Mutual of America Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.9M Buy
157,741
+5,537
+4% +$730K 0.19% 78
2026
Q1
$21.2M Sell
152,204
-1,689
-1% -$237K 0.24% 56
2025
Q4
$18.9M Sell
153,893
-1,738
-1% -$211K 0.2% 73
2025
Q3
$17.3M Sell
155,631
-8,657
-5% -$984K 0.18% 83
2025
Q2
$18.2M Sell
164,288
-2,815
-2% -$300K 0.2% 70
2025
Q1
$18.7M Sell
167,103
-5,174
-3% -$534K 0.22% 67
2024
Q4
$15.9M Sell
172,277
-5,121
-3% -$461K 0.17% 84
2024
Q3
$14.9M Sell
177,398
-1,807
-1% -$138K 0.16% 96
2024
Q2
$12.3M Buy
179,205
+580
+0.3% +$38.7K 0.13% 119
2024
Q1
$13.1M Sell
178,625
-1,732
-1% -$133K 0.14% 121
2023
Q4
$14.6M Sell
180,357
-8,546
-5% -$665K 0.17% 96
2023
Q3
$14.2M Sell
188,903
-5,566
-3% -$428K 0.17% 92
2023
Q2
$15M Buy
194,469
+572
+0.3% +$45.6K 0.17% 89
2023
Q1
$16.1M Sell
193,897
-1,232
-0.6% -$102K 0.19% 79
2022
Q4
$16.8M Buy
195,129
+4,914
+3% +$389K 0.21% 74
2022
Q3
$11.7M Buy
190,215
+2,528
+1% +$159K 0.16% 102
2022
Q2
$11.6M Buy
187,687
+2,962
+2% +$183K 0.15% 106
2022
Q1
$11M Buy
184,725
+1,759
+1% +$112K 0.12% 175
2021
Q4
$13.3M Buy
182,966
+141
+0.1% +$9.71K 0.13% 141
2021
Q3
$12.8M Buy
182,825
+815
+0.4% +$57.3K 0.13% 132
2021
Q2
$12.5M Buy
182,010
+1,393
+0.8% +$93K 0.12% 144
2021
Q1
$11.7M Buy
180,617
+3,806
+2% +$245K 0.12% 148
2020
Q4
$10.3M Sell
176,811
-5,673
-3% -$342K 0.12% 163
2020
Q3
$11.5M Sell
182,484
-7,616
-4% -$528K 0.15% 105
2020
Q2
$14.6M Sell
190,100
-92,332
-33% -$7.08M 0.21% 73
2020
Q1
$21.1M Buy
282,432
+867
+0.3% +$59.9K 0.35% 41
2019
Q4
$18.3M Sell
281,565
-114
-0% -$7.42K 0.23% 57
2019
Q3
$17.9M Buy
281,679
+34,625
+14% +$2.26M 0.25% 52
2019
Q2
$16.7M Buy
247,054
+3,807
+2% +$250K 0.24% 56
2019
Q1
$15.8M Buy
243,247
+8,111
+3% +$539K 0.23% 62
2018
Q4
$14.7M Buy
235,136
+14,187
+6% +$992K 0.24% 55
2018
Q3
$17.1M Buy
220,949
+8,601
+4% +$650K 0.24% 54
2018
Q2
$15M Sell
212,348
-436
-0.2% -$30.8K 0.22% 62
2018
Q1
$16M Buy
212,784
+2,703
+1% +$215K 0.25% 58
2017
Q4
$15.1M Buy
210,081
+1,108
+0.5% +$84.1K 0.23% 59
2017
Q3
$16.9M Buy
208,973
+12,254
+6% +$937K 0.28% 47
2017
Q2
$13.9M Sell
196,719
-5,398
-3% -$359K 0.24% 57
2017
Q1
$13.7M Buy
202,117
+11,791
+6% +$829K 0.24% 54
2016
Q4
$13.6M Buy
190,326
+12,012
+7% +$893K 0.26% 50
2016
Q3
$14.1M Buy
178,314
+8,614
+5% +$700K 0.28% 46
2016
Q2
$14.2M Sell
169,700
-10,915
-6% -$969K 0.3% 46
2016
Q1
$16.6M Sell
180,615
-4,893
-3% -$441K 0.37% 35
2015
Q4
$18.8M Sell
185,508
-2,746
-1% -$286K 0.42% 30
2015
Q3
$18.5M Buy
188,254
+1,604
+0.9% +$178K 0.44% 25
2015
Q2
$21.9M Sell
186,650
-2,349
-1% -$257K 0.48% 21
2015
Q1
$18.5M Buy
188,999
+193
+0.1% +$19.6K 0.4% 28
2014
Q4
$17.8M Buy
188,806
+98
+0.1% +$10.1K 0.4% 28
2014
Q3
$20.1M Sell
188,708
-5,271
-3% -$516K 0.48% 20
2014
Q2
$16.1M Sell
193,979
-4,525
-2% -$352K 0.38% 28
2014
Q1
$14.1M Buy
198,504
+7,083
+4% +$556K 0.34% 33
2013
Q4
$14.4M Sell
191,421
-9,520
-5% -$663K 0.35% 32
2013
Q3
$12.6M Buy
200,941
+4,303
+2% +$257K 0.34% 35
2013
Q2
$10.1M Buy
+196,638
New +$10.2M 0.3% 43

Other funds holding GILD

Mutual of America Capital Management's GILD Position: Q2 2026 in Review

Mutual of America Capital Management increased its Gilead Sciences (GILD) stake by 3.6% in Q2 2026, buying an estimated $730K and bringing the position to 157,741 shares worth $19.9M. The position accounts for 0.19% of the portfolio, ranked #78.

Mutual of America Capital Management first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $21.9M in Q2 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Mutual of America Capital Management held 157,741 shares of Gilead Sciences worth $19.9M as of Q2 2026.
  • Mutual of America Capital Management bought 5,537 Gilead Sciences shares in Q2 2026, an estimated $730K.
  • Gilead Sciences made up 0.19% of Mutual of America Capital Management's portfolio in Q2 2026, its #78 holding.
  • Mutual of America Capital Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • Mutual of America Capital Management's Gilead Sciences position peaked at $21.9M in Q2 2015.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.